Multiple Myeloma Research Consortium Shares its Insights into Effective and Efficient Biospecimen Management
News Jun 18, 2007
LabVantage has announced a webcast featuring the Multiple Myeloma Research Consortium (MMRC). The MMRC shares its insights into the implementation of LabVantage’s Sapphire BioBanking Solution for the effective and efficient biospecimen management system to support myeloma research throughout MMRC's partner network.
In the world of research, accurate, compliant and efficient management of biospecimens is critical. These specimens serve as the basis for research and development of tomorrow's drugs and medical treatments.
The MMRC reviews the challenges of sample collection, storage, management, and reporting associated with its myeloma specimens. It also addresses the specific barriers to specimen management and data warehousing faced by the MMRC, including how to: span the life cycle of the specimen, address the needs of multiple end users, capture correlating clinical data, maintain flexibility, and provide global visibility.
This webcast and further information about LabVantage's Sapphire BioBanking Solution are available at http://www.labvantage.com/products/biobanking/index.html.
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE